Login| Sign Up| Help| Contact|

Patent Searching and Data


Title:
NITROGEN-CONTAINING HETEROCYCLIC DERIVATIVE INHIBITOR, PREPARATION METHOD THEREFOR AND USE THEREOF
Document Type and Number:
WIPO Patent Application WO/2023/174406
Kind Code:
A1
Abstract:
The present invention relates to a nitrogen-containing heterocyclic derivative EGFR inhibitor, a preparation method therefor and a use thereof. In particular, the present invention relates to a compound represented by general formula (I), a preparation method therefor, a pharmaceutical composition containing the compound, and a use thereof as an EGFR inhibitor in treating cancer.

Inventors:
GAO PENG (CN)
ZENG MI (CN)
SUN GUANGJUN (CN)
CHENG FENGCHANG (CN)
XIU WENHUA (CN)
YU WENSHENG (CN)
Application Number:
PCT/CN2023/082178
Publication Date:
September 21, 2023
Filing Date:
March 17, 2023
Export Citation:
Click for automatic bibliography generation   Help
Assignee:
SHANGHAI HANSOH BIOMEDICAL CO LTD (CN)
JIANGSU HANSOH PHARMACEUTICAL GROUP CO LTD (CN)
International Classes:
C07D401/14; A61K31/506; A61P35/00; C07D417/14; C07D471/04
Domestic Patent References:
WO2021168074A12021-08-26
WO2021133809A12021-07-01
WO2021104305A12021-06-03
Foreign References:
CN115650958A2023-01-31
CN115724827A2023-03-03
US20160257682A12016-09-08
Other References:
BRYAN K. CHAN, EMILY J. HANAN, KRISTA K. BOWMAN, MARIAN C. BRYAN, DANIEL BURDICK, EMILY CHAN, YUAN CHEN, SAUNDRA CLAUSEN, TRISHA D: "Discovery of a Noncovalent, Mutant-Selective Epidermal Growth Factor Receptor Inhibitor", JOURNAL OF MEDICINAL CHEMISTRY, AMERICAN CHEMICAL SOCIETY, US, vol. 59, no. 19, 13 October 2016 (2016-10-13), US , pages 9080 - 9093, XP055497250, ISSN: 0022-2623, DOI: 10.1021/acs.jmedchem.6b00995
Attorney, Agent or Firm:
GE CHENG & CO., LTD. et al. (CN)
Download PDF: